PMID- 21472294 OWN - NLM STAT- PubMed-not-MEDLINE DCOM- 20121002 LR - 20130222 IS - 1791-3004 (Electronic) IS - 1791-2997 (Linking) VI - 3 IP - 4 DP - 2010 Jul-Aug TI - Phosphorylation of vasodilator stimulated phosphoprotein is correlated with cell cycle progression in HeLa cells. PG - 657-62 LID - 10.3892/mmr_00000312 [doi] AB - Vasodilator stimulated phosphoprotein (VASP) is known as an actin-binding protein. The phosphorylation of VASP plays an important role in its function. In a previous study, serine 157 phosphorylated VASP (p-VASP S157) was shown to be co-localized with alpha-tubulin on the spindle of SGC-7901 cells. In the present study, we demonstrated that the level of p-VASP S157 increases and has a peak which coincides with serine 10 phosphorylated histone 3 (p-H3 S10) during mitotic progression in a human cervical cancer cell line (HeLa cells). Application of protein kinase A inhibitor H89, protein kinase G inhibitor KT5823 and protein kinase C inhibitor Go6983, or a combination of these inhibitors, caused a partial decrease in p-VASP S157 and a delay in G2/M progression. Depletion of p-VASP S157 by VASP siRNA resulted in an increase in binucleated cells and x4n cells, a further delay in G2/M progression and the inhibition of HeLa cell proliferation. These results suggest that p-VASP S157 may play an important role in the G2/M transition and the completion of cytokinesis in HeLa cells. FAU - Tao, Yan AU - Tao Y AD - School of Medical Science and Laboratory Medicine, Jiangsu University, Jiangsu 212013, P.R. China. FAU - Chen, Yong-Chang AU - Chen YC FAU - Sang, Jian-Rong AU - Sang JR FAU - Xu, Wen-Rong AU - Xu WR LA - eng PT - Journal Article PL - Greece TA - Mol Med Rep JT - Molecular medicine reports JID - 101475259 EDAT- 2011/04/08 06:00 MHDA- 2011/04/08 06:01 CRDT- 2011/04/08 06:00 PHST- 2011/04/08 06:00 [entrez] PHST- 2011/04/08 06:00 [pubmed] PHST- 2011/04/08 06:01 [medline] AID - 10.3892/mmr_00000312 [doi] PST - ppublish SO - Mol Med Rep. 2010 Jul-Aug;3(4):657-62. doi: 10.3892/mmr_00000312.